Fennec Pharmaceuticals Inc (FRX.TO)
8.87
-0.10
(-1.11%)
CAD |
TSX |
Jun 21, 12:37
Fennec Pharmaceuticals Enterprise Value: 218.22M for June 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 20, 2024 | 218.22M |
June 19, 2024 | 222.05M |
June 18, 2024 | 222.05M |
June 17, 2024 | 228.33M |
June 14, 2024 | 226.56M |
June 13, 2024 | 231.07M |
June 12, 2024 | 229.97M |
June 11, 2024 | 235.71M |
June 10, 2024 | 239.54M |
June 07, 2024 | 233.80M |
June 06, 2024 | 229.70M |
June 05, 2024 | 224.78M |
June 04, 2024 | 219.04M |
June 03, 2024 | 219.04M |
May 31, 2024 | 225.33M |
May 30, 2024 | 233.25M |
May 29, 2024 | 240.90M |
May 28, 2024 | 230.25M |
May 27, 2024 | 223.42M |
May 24, 2024 | 223.42M |
May 23, 2024 | 239.54M |
May 22, 2024 | 242.27M |
May 21, 2024 | 239.54M |
May 17, 2024 | 232.98M |
May 16, 2024 | 228.06M |
Date | Value |
---|---|
May 15, 2024 | 233.25M |
May 14, 2024 | 246.91M |
May 13, 2024 | 348.00M |
May 10, 2024 | 341.17M |
May 09, 2024 | 318.71M |
May 08, 2024 | 318.71M |
May 07, 2024 | 318.71M |
May 06, 2024 | 314.61M |
May 03, 2024 | 316.80M |
May 02, 2024 | 316.80M |
May 01, 2024 | 316.80M |
April 30, 2024 | 316.80M |
April 29, 2024 | 316.80M |
April 26, 2024 | 314.13M |
April 25, 2024 | 320.09M |
April 24, 2024 | 320.09M |
April 23, 2024 | 320.09M |
April 22, 2024 | 320.09M |
April 19, 2024 | 320.63M |
April 18, 2024 | 346.38M |
April 17, 2024 | 346.38M |
April 16, 2024 | 361.29M |
April 15, 2024 | 358.04M |
April 12, 2024 | 367.25M |
April 11, 2024 | 367.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
70.09M
Minimum
Jun 26 2019
435.34M
Maximum
Mar 25 2024
229.51M
Average
219.82M
Median
Enterprise Value Benchmarks
Ionic Brands Corp | -- |
4Front Ventures Corp | 195.55M |
Green Thumb Industries Inc | 3.909B |
Lowell Farms Inc | -0.1276M |
Bright Minds Biosciences Inc | 0.2276M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 17.30M |
Revenue (Quarterly) | 34.21M |
Total Expenses (Quarterly) | 15.71M |
EPS Diluted (Quarterly) | 0.5527 |
Gross Profit Margin (Quarterly) | 97.83% |
Profit Margin (Quarterly) | 50.59% |
Earnings Yield | 0.46% |
Operating Earnings Yield | 3.33% |
Normalized Earnings Yield | 0.4769 |